openPR Logo
Press release

REI Systems Awarded $31M Health Resources and Services Administration Contract

10-21-2007 05:01 PM CET | IT, New Media & Software

Press release from: REI Systems, Inc.

REI Systems Continues 5-Year Partnership with HRSA Supporting Electronic Handbooks

Herndon, VA – October 9, 2007 - REI Systems (REI) announced today that it was awarded a contract by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) to continue support of the Electronic Handbooks (EHBs), HRSA’s enterprise program management system. REI will support a 1-year, $6.2M contract with options to extend the contract to 5-years and a funding ceiling of $31M. Under the terms of the contract, REI will continue to provide sustainment services for HRSA EHBs and further enhance the system to include modules for project management, performance site tracking, reporting services, integration services, performance measurement and financial tracking. New business processes will be automated to support HRSA’s Bureau of Primary Health Care (BPHC) and nine additional tasks can be exercised to automate additional business processes, interface with the HHS Grants Center of Excellence (CoE), conduct training, and provide backup and recovery services.

HRSA is the primary Federal agency for improving access to health care services for people who are uninsured, isolated or medically vulnerable. Comprising six bureaus and 12 offices, HRSA provides leadership and financial support to health care providers in every state and U.S. territory. HRSA grantees provide health care to uninsured people, people living with HIV/AIDS, and pregnant women, mothers and children. They train health professionals and improve systems of care in rural communities. HRSA oversees organ, tissue and blood cell (bone marrow and cord blood) donation and vaccine injury compensation programs, and maintains databases that protect against health care malpractice and health care waste, fraud and abuse.

“HRSA has been highly successful in supporting a large constituency and a tremendous workload through the use of EHBs – 1,200 federal employees, 20,000 external users, 200 active programs, 15,000 annual awards, more than $6B in annual federal financial assistance – what they have accomplished through the use of this technology is significant and REI is proud to be a part of it” says Veer Bhartiya, REI Systems President. “We have worked in partnership with HRSA since 2001 and welcome their adoption of EHBs as the enterprise business process management system to support their mission of providing the resources and services needed to improve access to quality health care. REI is committed to providing HRSA with the combination of technical and subject matter expertise that will continue to produce significant results to HRSA in meeting its goals.”

Subhash Kari
skari@reisys.com
Tel. (703) 480.9163

About REI Systems, Inc.

REI Systems (http://www.reisys.com) is a leading provider of web-enabled solutions, electronic performance support systems, and knowledge management tools for the Federal Government and the commercial and industrial sectors. Drawing upon our mission to deliver reliable, effective, and innovative solutions – the company works daily to solve complex homeland security, defense, health resources, criminal justice, and aeronautics issues. REI Systems’s support of these issues is strengthened by its results driven approach and commitment to exceeding customer expectations. Since 1989, REI Systems has been serving major corporations and government at all levels. More than 175 employees serve these clients offices based in the Washington, D.C. metropolitan area.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release REI Systems Awarded $31M Health Resources and Services Administration Contract here

News-ID: 30950 • Views:

More Releases from REI Systems, Inc.

REI Systems Attains CMMI Level 3 Certification for Systems and Software Engineer …
REI Systems Continues Its Commitment to Delivery Excellence by Attaining the Internationally Recognized Rating for Superior Quality Herndon, VA – May 16, 2008 - REI Systems (REI) announced today that the company has been appraised as fully compliant at Maturity Level 3 with the Software Engineering Institute’s (SEI) Capability Maturity Model Integration for Development (CMMI®-DEV) version 1.2. The rating is conferred on companies that have established well-defined, repeatable, and effective

More Releases for HRSA

Upsurge in the Cloud-Based SaaS Adoption propels the Global Team Collaboration S …
According to a new market research report published by Inkwood Research, the Global Team Collaboration Software Market is projected to evolve at a CAGR of 10.89% during the forecasting years of 2021-2028. "Browse 41 market Data Tables and 45 Figures spread over 179 Pages, along with an in-depth TOC on Global Team Collaboration Software Market Forecast 2021-2028." REQUEST CUSTOMIZATION LINK- https://www.inkwoodresearch.com/reports/team-collaboration-software-market/ REQUEST FREE SAMPLE LINK- https://www.inkwoodresearch.com/reports/team-collaboration-software-market/#request-free-sample VIEW TABLE OF CONTENT LINK- https://www.inkwoodresearch.com/reports/team-collaboration-software-market/#table-of-contents Team collaboration
Fujimycin Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global fujimycin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Fujimycin is an immunosuppressive drug used mainly after an allogeneic organ transplant to lower the risk of organ rejection. It is also known as Tacrolimus. The major factor expected to drive the market growth is the increasing number of transplant surgeries globally along with its function to prevent rejection of a kidney, heart,
Global Bionics Market Size, Share, Analysis, Industry Report and Forecast 2021-2 …
The global bionics market is estimated to grow at a significant CAGR during the forecast period. The rising demand for organ transplantation and a large increase in neurostimulation treatments are two key factors driving market expansion. Because of the expanding number of patients with heart failure, renal failure, and liver disease, the need for organ transplantation has increased dramatically. According to Health Resources and Services Administration (HRSA), in the US,
Centered Mind Therapy Adds Gina Easton as Therapist to Clinical Team
Centered Mind Therapy has added Gina Easton as a therapist to their clinical team. Centered Mind Therapy is a therapy practice that operates in New York, California, and Texas, and specialize in anxiety, depression, eating disorders, body image, life coaching, life transitions, postpartum depression, relationships, self esteem, trauma, and PTSD. Ms. Easton completed her undergraduate studies at the University of California Santa Cruz, and obtained a Masters of Social Work from
Hemophilia Treatment Market Size, Share, Growth, Analysis and Forecast to 2027 - …
According to a new market research study titled 'Hemophilia treatment Market - Global Analysis and Forecasts by Product, Disease, Treatment Type, Therapy, and End User, the global hemophilia treatment market is expected to reach US$ 20,507.92 Mn in 2027 from US$ 12,797.36 Mn in 2019. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. The report highlights the trends prevalent in the global hemophilia treatment market
Newborn Screening Market 2019 | Development in screening technologies by key Pla …
Several governments are taking initiative in increasing awareness about newborn screening tests and are offering free screening services in some regions. For instance, in September 2018, the Florida Department of Health launched the Newborn Screening (NBS) Web Order Application. This statewide initiative has been developed to ensure efficiency and accuracy of newborn screening information submitted to the Bureau of Public Health Laboratories. Moreover, novel biomarkers and analytical technologies are driving the